Eli Lilly & Co
LLY- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000059478
In the last 90 days, Eli Lilly & Co insiders filed 0 open-market purchases and 2 sales; 4,664 institutions reported holding it in 13F filings for Q2 2026, worth $942.9B in total; 4 superinvestors hold it, including ARK Invest and Soros Fund Management.
Key figures
- Market capClose on Nov 9, 2026
- $1.33T
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $14.7M in total
- 2
- 13F holdersQ2 2026, +312 vs. previous quarter
- 4,664
- 13F valueReported value at the end of Q2 2026
- $942.9B
- Superinvestors holdingAt the end of Q2 2026
- 4
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $65.2B
- +44.7% year over year
- Net income, FY2025
- $20.6B
- +94.9% year over year
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- $24.4B
- +38.6% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 6.96M
- Shares sold short
- Change
- −74.6K
- −1.1% vs. previous
- Days to cover
- 3.04
- At average daily volume
Superinvestors holding LLY, Q2 2026
Go to the superinvestors tab4 superinvestors report holding Eli Lilly & Co on Form 13F. Percentages are the stock's share of each portfolio.
| Superinvestor | Weight | Value |
|---|---|---|
| Duquesne Family Office | 0.3% | $14.8M |
| Harris Associates (Oakmark) | <0.1% | $517.0K |
Latest insider trades
See all insider tradesOpen-market purchases and sales by Eli Lilly & Co insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2026 (view filing)4:14 PM ET | Nov 2 | 1 day | Hakim AnatEVP, GC & Secretary | SSale | −5.00K | $1,402.52 | −$7.01M | −54.7%4.14K after | 10b5-1 |
| Aug 18, 2026 (view filing)4:20 PM ET | Aug 17 | 1 day | Jonsson PatrikEVP & President, LLY Int'l | SSale | −6.50K | $1,175.10 | −$7.64M | −10.7%54.1K after | 10b5-1 |
| Aug 11, 2026 (view filing)4:31 PM ET | Aug 10 | 1 day | Zakrowski Donald ASVP, Finance, & CAO | SSale | −2.00K | $1,185.01 | −$2.37M | −56.7%1.53K after | 10b5-1 |
| Aug 10, 2026 (view filing)4:19 PM ET | Aug 7 | 3 days | Hakim AnatEVP, GC & Secretary | SSale | −5.00K | $1,190.00 | −$5.95M | −29.6%11.9K after | 10b5-1 |
| Jun 11, 2026 (view filing) | Jun 10 | 1 day | Yuffa IlyaEVP&Pres, LLY USA&Global Capab | SSale | −2.50K | $1,150.77 | −$2.88M | −7.7%29.8K after | 10b5-1 |
| May 7, 2026 (view filing) | May 6 | 1 day | Lilly Endowment IncOther: Former 10% Shareholder | SSale | −15.8K | $995.36 | −$15.8M | 0.0%91.9M after | 2 lots |
| Jan 8, 2026 (view filing) | Jan 7 | 1 day | Lilly Endowment Inc10% Owner | SSale | −292.1K | $1,103.48 | −$322.4M | −0.3%91.9M after | 30 lots |
| Jan 6, 2026 (view filing) | Jan 5 | 1 day | Lilly Endowment Inc10% Owner | SSale | −1.39K | $1,085.01 | −$1.51M | 0.0%92.2M after | |
| Dec 30, 2025 (view filing) | Dec 29 | 1 day | Lilly Endowment Inc10% Owner | SSale | −3.59K | $1,085.04 | −$3.90M | 0.0%92.2M after | |
| Dec 29, 2025 (view filing) | Dec 24 | 5 days | Lilly Endowment Inc10% Owner | SSale | −2.63K | $1,085.17 | −$2.85M | 0.0%92.2M after |
Top 10 13F holders, Q2 2026
See all 4,664 holdersThe largest institutional positions in Eli Lilly & Co at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lilly Endowment Inc | 90,376,978 | $108.4B | 100.00% | −1,520,000−1.7% | Reduced |
| BlackRock, Inc. | 67,540,400 | $81.0B | 1.21% | +1,159,558+1.7% | Added |
| Vanguard Capital Management LLC | 53,528,868 | $64.2B | 1.37% | +167,094+0.3% | Added |
| The PNC Financial Services Group, Inc. | 51,322,720 | $61.6B | 30.51% | −6,1880.0% | Reduced |
| State Street Corp | 36,215,754 | $43.4B | 1.28% | +605,752+1.7% | Added |
| FMR LLC | 28,462,475 | $34.1B | 1.48% | +2,121,444+8.1% | Added |
| Capital Research Global Investors | 20,873,140 | $25.0B | 3.49% | −3,759,507−15.3% | Reduced |
| Vanguard Portfolio Management LLC | 20,859,217 | $25.0B | 1.13% | −117,810−0.6% | Reduced |
| Geode Capital Management, LLC | 20,310,858 | $24.3B | 1.29% | +118,994+0.6% | Added |
| Morgan Stanley | 16,226,398 | $19.5B | 1.03% | +788,940+5.1% | Added |
Holders of 5% or more of LLY
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Eli Lilly & Co.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lilly Endowment Inc | 13G/A | 9.60%90.1M shares | 0.00 ppfrom 9.60% | Jan 21, 202112 filings | Oct 19, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 6.48%61.3M shares | New | May 1, 20261 filing | May 1, 2026 | SEC |
| The PNC Financial Services Group, Inc. | 13G/A | 5.39%51.2M shares | – | Feb 12, 20216 filings | Feb 7, 2025 | SEC |
Politician trades
All politician trades in LLY38 members of Congress reported 139 trades in Eli Lilly & Co since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 24, 2026 |  John Boozman Senate · AR | Sell (partial) | $1K-$15K |
| Aug 7, 2026 |  Michael A. Rulli House · OH | Sell | $1K-$15K |
| Aug 7, 2026 | Michael A. Rulli House · OH | Sell | $1K-$15K |
| Aug 7, 2026 | Michael A. Rulli House · OH | Buy | $1K-$15K |
| Aug 5, 2026 |  Tommy Tuberville Senate · AL | Sell (full) | $15K-$50K |
Senate · AR · Aug 24, 2026
Sell (partial)$1K-$15K
House · OH · Aug 7, 2026
Sell$1K-$15K
House · OH · Aug 7, 2026
Sell$1K-$15K
House · OH · Aug 7, 2026
Buy$1K-$15K
Senate · AL · Aug 5, 2026
Sell (full)$15K-$50K